Family History and Lipoprotein(a) Contribute Independently to Risk Assessment and Clinical Management

This editorial accompanies a study (by Mehta and colleagues) showing that lipoprotein(a) and a family history of premature heart disease each add independent risk information. Durrington’s commentary draws out why that matters for everyday practice.

His argument is that family history and Lp(a) are complementary, not redundant. Family history captures a broad mix of inherited risks; Lp(a) captures one specific, measurable, causal factor. Knowing both refines an individual’s risk estimate more than either alone — and both, he argues, deserve a place in risk-prediction models and routine assessment.

As an editorial, this is informed expert opinion rather than original data. Its function is interpretive: contextualizing a primary study and advocating for broader adoption of two underused pieces of risk information.

We rate the evidence limited by type — it is commentary, not research — but its clinical significance is reasonable, because it usefully frames how two inherited risk signals should be combined in the kind of efficient, individualized assessment this library favors.